Overview and Analysis of the Cost of Drug Programs in Poland: Public Payer Expenditures and Coverage of Cancer and Non-Neoplastic Diseases Related Drug Therapies from 2015–2018 Years

BACKGROUND: In Poland drug programmes developed by the Minister of Health and financed by the National Health Fund are special reimbursement frameworks of innovative, expensive, and mostly hospital based medical products used for a small number of patients. RESEARCH DESIGN: The research presented in...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Pharmacol
Autori principali: Mela, Aneta, Poniatowski, Łukasz A., Drop, Bartłomiej, Furtak-Niczyporuk, Marzena, Jaroszyński, Janusz, Wrona, Witold, Staniszewska, Anna, Dąbrowski, Jan, Czajka, Anna, Jagielska, Beata, Wojciechowska, Monika, Niewada, Maciej
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2020
Soggetti:
Pharmacology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7456857/
https://ncbi.nlm.nih.gov/pubmed/32922285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.01123
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi